Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, To Board Of Directors

Blend Therapeutics, Inc., a biopharmaceutical company discovering new classes of medicines to treat cancer, announced today that it has appointed Dennis A. Ausiello, MD, to the company’s Board of Directors. With deep experience and a distinguished record of leadership and accomplishment in medicine and scientific research, Dr. Ausiello brings a seasoned and unique perspective to support Blend’s continued growth and advancement as an innovative oncology drug developer.

Help employers find you! Check out all the jobs and post your resume.

Back to news